NEW YORK (GenomeWeb) – Sequenom today reported preliminary 2015 revenue of $128 million, below analyst estimates of $130 million.

The company also said it accessioned 42,000 total commercial diagnostic test samples in the fourth quarter, up from 41,000 in the third quarter. Of the 42,000 tests, 37,300 were noninvasive prenatal test samples. In addition, Sequenom accessioned 3,000 of its MaterniT Genome test in Q4, the assay's first full quarter of sales.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.